200 related articles for article (PubMed ID: 20554721)
21. Nucleotide specificity of human deoxycytidine kinase.
Shewach DS; Reynolds KK; Hertel L
Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase.
Shafiee M; Griffon JF; Gosselin G; Cambi A; Vincenzetti S; Vita A; Eriksson S; Imbach JL; Maury G
Biochem Pharmacol; 1998 Nov; 56(9):1237-42. PubMed ID: 9802336
[TBL] [Abstract][Full Text] [Related]
23. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase.
Usova EV; Eriksson S
Eur J Biochem; 1997 Sep; 248(3):762-6. PubMed ID: 9342227
[TBL] [Abstract][Full Text] [Related]
24.
Chen BY; Ghezzi C; Villegas B; Quon A; Radu CG; Witte ON; Clark PM
J Nucl Med; 2020 May; 61(5):757-763. PubMed ID: 31653711
[TBL] [Abstract][Full Text] [Related]
25. A novel radiochemical approach to 1-(2'-deoxy-2'-[(18) F]fluoro-β-d-arabinofuranosyl)cytosine ((18) F-FAC).
Meyer JP; Probst KC; Trist IM; McGuigan C; Westwell AD
J Labelled Comp Radiopharm; 2014 Sep; 57(11):637-44. PubMed ID: 25257474
[TBL] [Abstract][Full Text] [Related]
26. Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2'-deoxyadenosine, 2'-deoxyguanosine and their analogs.
Gaubert G; Gosselin G; Boudou V; Imbach JL; Eriksson S; Maury G
Biochimie; 1999 Nov; 81(11):1041-7. PubMed ID: 10575360
[TBL] [Abstract][Full Text] [Related]
27. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
[TBL] [Abstract][Full Text] [Related]
28. TMSOTf assisted synthesis of 2'-deoxy-2'-[18F]fluoro-β-D-arabinofuranosylcytosine ([18F]FAC).
Gangangari KK; Humm JL; Larson SM; Pillarsetty NVK
PLoS One; 2018; 13(5):e0196784. PubMed ID: 29715301
[TBL] [Abstract][Full Text] [Related]
29. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
30. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
31.
Salas JR; Chen BY; Wong A; Cheng D; Van Arnam JS; Witte ON; Clark PM
J Nucl Med; 2018 Oct; 59(10):1616-1623. PubMed ID: 29700125
[TBL] [Abstract][Full Text] [Related]
32. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
Arnér ES; Spasokoukotskaja T; Eriksson S
Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886
[TBL] [Abstract][Full Text] [Related]
33. Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.
Radu CG; Shu CJ; Nair-Gill E; Shelly SM; Barrio JR; Satyamurthy N; Phelps ME; Witte ON
Nat Med; 2008 Jul; 14(7):783-8. PubMed ID: 18542051
[TBL] [Abstract][Full Text] [Related]
34. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.
Antonios JP; Soto H; Everson RG; Moughon DL; Wang AC; Orpilla J; Radu C; Ellingson BM; Lee JT; Cloughesy T; Phelps ME; Czernin J; Liau LM; Prins RM
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10220-10225. PubMed ID: 28874539
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.
Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB
J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
37. Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells.
Leegwater PA; De Abreu RA; Albertioni F
Cancer Lett; 1998 Aug; 130(1-2):169-73. PubMed ID: 9751270
[TBL] [Abstract][Full Text] [Related]
38. Predicting Gemcitabine Delivery by
Russell J; Grkovski M; O'Donoghue IJ; Kalidindi TM; Pillarsetty N; Burnazi EM; Kulick A; Bahr A; Chang Q; LeKaye HC; de Stanchina E; Yu KH; Humm JL
J Nucl Med; 2021 Feb; 62(2):195-200. PubMed ID: 32646874
[No Abstract] [Full Text] [Related]
39. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.
Eriksson S; Kierdaszuk B; Munch-Petersen B; Oberg B; Johansson NG
Biochem Biophys Res Commun; 1991 Apr; 176(2):586-92. PubMed ID: 2025274
[TBL] [Abstract][Full Text] [Related]
40. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents.
Verri A; Focher F; Priori G; Gosselin G; Imbach JL; Capobianco M; Garbesi A; Spadari S
Mol Pharmacol; 1997 Jan; 51(1):132-8. PubMed ID: 9016355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
